Related Experiment Video
Updated: Jun 12, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Inhibition of beta-catenin/Tcf signaling by flavonoids
1Department of Applied Chemistry, Dongduk Women's University, Seoul 136-714, South Korea. sypark21@dongduk.ac.kr
Abstract:
Functional activation of beta-catenin/T-cell factor (Tcf) signaling has been implicated in human carcinogenesis. We identified the inhibitory effect of various polyphenolic flavonoid compounds against beta-catenin/Tcf signaling in beta-catenin-activated cells. Genistein, kaempferol, isorhamnentin, and baicalein inhibited the transcriptional activity of beta-catenin/Tcf in HEK293 cells transiently transfected with a constitutively active mutant beta-catenin gene. To investigate the inhibitory mechanism, electrophoresis mobility shift assay, immunoprecipitation, and Western blot experiments were performed. The shift assay showed that the binding of Tcf complexes with its specific DNA-binding sites was suppressed by four kinds of flavonoids. Immunoprecipitation analysis also showed that the binding of beta-catenin to Tcf-4 was also disrupted by these flavonoids. Western blot analysis showed a decreased level of beta-catenin in nucleus caused by genistein. Genistein also decreased phosphorylation of Akt and GSK3 beta. Taken together, these results suggest that the polyphenolic flavonoids genistein, kaempferol, isorhamnentin, and baicalein are negative regulators of beta-catenin/Tcf signaling and their inhibitory mechanism is related to the decreased binding of beta-catenin/Tcf complexes to consensus DNA.
Insights
Polyphenolic flavonoids like genistein inhibit beta-catenin/Tcf signaling, a key pathway in cancer. These compounds reduce the binding of beta-catenin/Tcf complexes to DNA, acting as negative regulators.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Beta-catenin/T-cell factor (Tcf) signaling is crucial in human carcinogenesis.
- Understanding modulators of this pathway is vital for cancer therapy.
Purpose of the Study:
- To investigate the inhibitory effects of polyphenolic flavonoids on beta-catenin/Tcf signaling.
- To elucidate the molecular mechanisms underlying this inhibition.
Main Methods:
- HEK293 cells were transfected with a constitutively active mutant beta-catenin gene.
- Electrophoresis mobility shift assay, immunoprecipitation, and Western blot were employed.
- Analysis of beta-catenin/Tcf transcriptional activity and protein interactions.
Main Results:
- Genistein, kaempferol, isorhamnentin, and baicalein suppressed beta-catenin/Tcf transcriptional activity.
- These flavonoids disrupted the binding of beta-catenin to Tcf-4.
- Genistein reduced nuclear beta-catenin levels and decreased Akt and GSK3 beta phosphorylation.
Conclusions:
- Polyphenolic flavonoids genistein, kaempferol, isorhamnentin, and baicalein negatively regulate beta-catenin/Tcf signaling.
- Their inhibitory mechanism involves reducing beta-catenin/Tcf complex binding to DNA.
- These findings highlight potential therapeutic roles for flavonoids in cancer.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Inhibition of CDK Activity
Inhibition of Cdk Activity
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
